The Diagnostic Journey: Genetics, Imaging, and Eye Exams

Confirming a diagnosis of MPAN (Mitochondrial membrane protein-associated neurodegeneration) is a multi-step process that combines genetic testing, specialized brain imaging, and detailed eye examinations. Because the condition is rare and shares features with other movement disorders, these tests work together like pieces of a puzzle to provide a clear answer.

The Role of the C19orf12 Gene

At the heart of MPAN is the C19orf12 gene. This gene provides instructions for a small protein found in the mitochondria (the cell’s power plants) and the endoplasmic reticulum (the cell’s manufacturing center) ^[1][2].

While researchers are still mapping out exactly what this protein does, they think that when it is missing or broken, it may disrupt how the cell handles fats (lipids), energy, and waste removal (mitophagy) ^[3][4]. These “housekeeping” failures make brain cells more vulnerable to oxidative stress and eventually cause iron to build up where it shouldn’t, leading to the symptoms of the disease ^[5][6].

Reading Your MRI: Iron and Streaking

Magnetic Resonance Imaging (MRI) is the primary tool doctors use to look for signs of MPAN in the brain. The most characteristic finding is a buildup of iron in two specific areas: the globus pallidus and the substantia nigra ^[7]. On certain types of MRI scans (T2 or T2* weighted), these areas will look unusually dark (hypointensity) ^[8].

• Medial Medullary Lamina Streaking: Doctors often look for a thin, bright line (hyperintensity) on T2 scans within the dark iron-filled areas. This is called the medial medullary lamina ^[7].
• The “Eye-of-the-Tiger” Sign: You may hear about a pattern called the “eye-of-the-tiger,” which is common in another NBIA disorder called PKAN. While this pattern occasionally appears in MPAN, it is not a standard feature and is usually absent ^[7][9].
• A Note on Timing: It is crucial to know that an early MRI can look completely normal. Iron often takes time to accumulate; in some cases, a scan may not show iron buildup until several years after symptoms begin ^[10][11].

Genetic Testing and Inheritance

Genetic testing is the most direct way of confirming MPAN. Most families will receive a report describing variants in the C19orf12 gene.

• Biallelic (Recessive) Inheritance: This is the established form of MPAN. It means you have two pathogenic or likely pathogenic variants—one inherited from each parent. This can be homozygous (two copies of the same variant) or compound heterozygous (two different variants in the same gene) ^[7][12]. Parents are typically tested to prove the variants are on opposite copies (“in trans”).
• Variants of Uncertain Significance (VUS): Sometimes a report returns a “VUS”. A VUS does not confirm a diagnosis on its own, and a single heterozygous variant (especially a VUS) does not establish MPAN.
• Monoallelic/Dominant Reports: While rare research reports describe families with single variants proposed as dominant or de novo, these are exceptions rather than established MPAN inheritance ^[13][6]. Families with one detected variant should consult a clinical geneticist for deletion/duplication testing and to explore alternative diagnoses.

The Importance of Eye Exams

Because MPAN affects the eyes differently than other disorders, an ophthalmologist’s evaluation is a vital part of the diagnosis. Doctors select specific tests based on symptoms.

• Optic Disc Pallor: The doctor will look at the back of the eye for a “pale” optic nerve, which indicates optic atrophy (thinning of the nerve) ^[14].
• Visual Evoked Potential (VEP): This test measures how fast signals travel from the eye to the brain. In MPAN, these signals are often delayed ^[14].
• Electroretinogram (ERG): This test measures the health of the retina. In MPAN, the ERG is typically normal, which helps doctors distinguish it from other conditions where the retina itself is damaged ^[14].

A combination of optic nerve thinning and a normal retina (normal ERG) is a supportive clue for MPAN, though it is not purely diagnostic as it occurs in other mitochondrial neuropathies ^[14].